Drug recall · April 9, 2025
Atorvastatin Calcium Tablets USP 40 mg recall
Why: Failed dissolution specifications: lower than specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Atorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA, Manufactured by: Recipharm Pharmaservices PVT, Ltd Bengaluru, INDIA -562-123, NDC 70377-079-13
- Lots / codes
Lot#: AVC24035, Exp 03/31/26
- Quantity
- 2184 bottles
- Company
- Biocon Pharma Inc, Iselin, NJ
- Distribution
- U.S.A. nationwide
- Initiated
- March 17, 2025 · Voluntary: Firm initiated
- Classified
- March 28, 2025
- Reported
- April 9, 2025
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Atorvastatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.